Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

Comparison of the efficacy and safety of T2750 and Vismed® in the treatment of moderate to severe Dry Eye Syndrome

Inclusion Criteria:

• Signed and dated informed consent
• Male or female aged from ≥ 18 years old.
• Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to study selection.

Exclusion Criteria:

• Best far corrected visual acuity < 1/10
• Severe blepharitis
• Severe Dry Eye
• Eyelid malposition
• Known hypersensitivity to one of the components of the study medications or test products.
• Pregnant or breast-feeding woman.
• Woman of childbearing age (neither menopausal, nor hysterectomised, nor sterilized) not using effective contraception (oral contraceptives, intra-uterine device, contraceptive implant or condoms).
• Inability of patient to understand the study procedures and thus inability to give informed consent.
• Non compliant patient (e.g. not willing to attend the follow-up visits, way of life interfering with compliance).
• Already included once in this study.
• Patient under guardianship.